Boldenone Undecylenate 250mg Genetic

Boldenone Undecylenate 250mg Genetic is a certified pharmaceutical-grade analytical reference standard containing 250 mg/mL of Boldenone Undecylenate in 10 mL multidose vials. Produced under strict GMP-aligned conditions by Genetic Pharmaceuticals, each batch is verified to ≥99.5% purity using orthogonal methods (HPLC, GC-MS, NMR, FTIR) and supplied exclusively to licensed anti-doping, forensic, and academic institutions for calibration, method validation, and residue testing. Full Certificate of Analysis with raw data included. Not for human or veterinary administration.

Physical and Chemical Properties

• Concentration: 250 mg/mL Boldenone Undecylenate
• Volume: 10 mL per vial
• Appearance: Clear golden-yellow viscous oil
• Molecular Formula: C₃₀H₄₄O₃
• Molecular Weight: 452.67 g/mol
• CAS Number: 13103-34-9
• Carrier Oil: Refined grape seed oil + benzyl benzoate/benzyl alcohol

(138 words)

Boldenone Undecylenate 250mg Genetic — Clinical & Pharmaceutical Reference Guide

Introduction

Boldenone Undecylenate 250mg Genetic is a pharmaceutical-grade 250 mg/mL certified reference material of Boldenone Undecylenate manufactured by Genetic Pharmaceuticals specifically for professional analytical and forensic laboratories. This concentration has become one of the most commonly encountered formulations worldwide, making it an indispensable mid-to-high range standard for WADA-accredited anti-doping labs, national forensic services, and university research programs. Genetic’s ultra-pure reference provides licensed institutions with fully characterized material essential for accurate detection, quantification, and confirmation of boldenone and its metabolites.

Key Features & Scientific Relevance

• Pharmaceutical-grade purity ≥99.5% verified by multiple orthogonal analytical techniques
• Precise 250 mg/mL concentration in 10 mL vials – ideal for authentic calibrators and QC samples
• Primary reference in ISO/IEC 17025-accredited and GLP-compliant laboratories
• Complete analytical data package suitable for regulatory submissions and peer-reviewed publications
• Secure, compliance-focused distribution for Schedule III controlled substances

Product Specifications

• Product Reference: Boldenone Undecylenate 250mg Genetic
• Active Ingredient: Boldenone Undecylenate 250 mg/mL
• Presentation: 10 mL sterile glass vial with bromobutyl stopper and tamper-evident flip-off cap
• Excipients: Grape seed oil USP, benzyl benzoate 20–25%, benzyl alcohol 2%
• IUPAC Name: (17β)-3-Oxoandrosta-1,4-dien-17-yl undec-10-enoate
• Classification: Long-acting anabolic-androgenic steroid ester (Schedule III / international equivalent)

Applications & Usage

Boldenone Undecylenate 250mg Genetic is restricted to regulated professional applications:

• Validation of LC-MS/MS and GC-MS screening/confirmation methods
• Preparation of matrix-matched calibration curves and quality-control materials
• Forensic confirmation of boldenone administration in human and equine samples
• Research into ester hydrolysis kinetics and phase II metabolism
• Inter-laboratory proficiency testing and external quality assurance

All handling requires documented chain-of-custody and appropriate controlled-substance licensing.

Purity & Analytical Testing

Every batch receives exhaustive characterization:

• HPLC-UV/DAD: ≥99.5% assay with full impurity profile
• GC-MS (TMS): Characteristic ions m/z 206, 296, 410, 452
• Quantitative 1H/13C NMR: Internal standard calibration against certified references
• FTIR: Ester carbonyl 1730 cm⁻¹, conjugated dienone 1655 cm⁻¹

Full raw data and spectra supplied with each vial.

Safety & Handling Guidelines

Boldenone Undecylenate is classified Repr. 1B / potential carcinogen. Required controls:

• Minimum PPE: nitrile gloves, lab coat, safety goggles, fume hood
• Storage: 2–8 °C, protected from light; do not freeze
• Double-locked controlled-substance storage
• Disposal only via licensed hazardous waste contractor

Secure & Confidential Distribution

Delivery to verified institutions in unmarked, temperature-monitored compliance packaging via tracked courier. Documentation includes:

• Batch-specific Certificate of Analysis- Safety Data Sheet- Controlled-substance forms (where required)

Possession requires valid DEA Schedule III registration or equivalent international licensing.

Why Choose This Reference Material?

• Exact 250 mg/mL concentration matches the most prevalent current formulations
• Produced by Genetic Pharmaceuticals with exceptional batch-to-batch reproducibility
• Comprehensive analytical documentation suitable for publication and regulatory filings
• Trusted globally by anti-doping agencies, forensic institutes, and academic laboratories

Legal & Safety Disclaimer

Boldenone Undecylenate 250mg Genetic is supplied exclusively as an analytical reference standard for licensed laboratories and accredited research institutions. It is NOT FOR HUMAN OR VETERINARY USE, NOT AVAILABLE FOR INDIVIDUAL PURCHASE, and NOT INTENDED for self-administration. Unauthorized possession or distribution violates controlled-substance laws in most jurisdictions. Recipients bear full legal responsibility for compliance.

FAQ Section

What is the active compound? Boldenone Undecylenate 250 mg/mL — long-acting ester prodrug of boldenone.

Is it a controlled substance? Yes — Schedule III (US) and equivalently regulated worldwide.

How is concentration verified? Quantitative NMR (qNMR) + reverse-phase HPLC with internal standardization.

Recommended storage? 2–8 °C, protected from light. Stable ≥36 months.

Who may purchase? Only accredited laboratories and institutions with valid controlled-substance licenses.

CoA provided? Yes — comprehensive CoA with full raw analytical data and spectra included.